В России начнут применять отечественную вакцину против рака мозга

Russia is set to begin using a domestically developed vaccine aimed at treating brain cancer. This innovative treatment represents a significant step forward in the country's efforts to combat oncological diseases. The vaccine's application is expected to offer a new therapeutic option for patients diagnosed with this challenging form of cancer.

This development matters as it introduces a new, locally produced treatment option for brain cancer, potentially improving patient outcomes and advancing Russia's biopharmaceutical capabilities.